1 / 69

Diabetes mellitus - patophysiology

Diabetes mellitus - patophysiology. Diabetes mellitus (DM). It is a group of chronic, progressive, etiopathologically different diseases and their connecting typical feature is hyperglycaemia. DM is caused by absolute or relative insufficiency of insulin secretion.

bjorn
Download Presentation

Diabetes mellitus - patophysiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Diabetes mellitus - patophysiology

  2. Diabetes mellitus (DM) • It is a group of chronic, progressive, etiopathologically different diseases and their connecting typical feature is hyperglycaemia. • DM is caused by absolute or relative insufficiency of insulin secretion. • It is accompanied by complex disorder in metabolisms of carbohydrates, lipids and proteins. Basic terms: Glycaemia Hyperglycaemia Hypoglycaemia

  3. Diabetes mellitus (DM) It leads to high risk of morbidity, invalidity and mortality. It belongs to vascular diseases – damage of vascular wall with severe consequences!!!!

  4. Cause of death in type diabetes Cardiovascular complications others

  5. Physiology of glucoregulation Hormonal • insulin • glucagon, adrenalin, STH, cortisol – antagonists Autoregulation (substrate regulation) β-cells=glucose sensor Nervous infl. – PSY ↓ glu - SY ↑ glu 4 – 8 mmol/l

  6. Hormons regulating glycaemia • Pancreas contains 1 million of Langerhans islets. • In each islet - 3 000 of endocrine cells • A cells ….…Glucagon • D cells …….Somatostatin • B cells…...Insulin • PP cells …...Pancreatic polypeptid

  7. Discovery of insulin

  8. Production of insulin

  9. Anatomy of pancreatic islet

  10. Hormon circulation in islets

  11. Glucose – a main modulator of insulin secretion

  12. Modulators of insulin secretion

  13. Insulin and its receptora key moment of postreceptor activity is a translocation of glucose transporter GLUT4into the membrane of muscle and adipose cells insulin receptor

  14. Glucose homeostasis PLAYERS: • glucose • insulin • insulin receptor • glucose transporter • GLUT1 (ery, CNS, muscles): gly 5 – 7 mmol/l • GLUT2 (liver, kidney, gut, β- cells): 7 – 20mmol/l • GLUT3 (CNS): 1,6mmol/l • GLUT4 (muscles, adipose tissue): 5 mmol/l, transporter concentration is regulated by insulin!!!!!! • GLUT5 (jejunum): fructose absorption

  15. Insulin independent – CNS, blood elements, in case of high blood glucose or during physical activity Insulin dependent – muscles, adipose tissue, liver, gut gut glucose liver • gluconeogenesis • glycogenolysis glycolysis glycogenesis

  16. glucose IR GLUT4

  17. insulin glucose IR GLUT4

  18. insulin glucose IR GLUT4

  19. insulin glucose α Inzulin receptor tyrozinkinase β insulin receptor substrate 1 - 3 GLUT 4 mitogen activating proteinkinase PI-3-kinase glycogesynthesis lipogenesis proteosynthesis growing activity genes expresion METABOLIC ACTIVITY Insulin function

  20. Function of insulin Liver : ↓ gluconeogenesis ↑ protein synthesis ↓ glycogenolysis ↓ FFA oxidation Muscle: ↑ absorption and glucose oxidation ↑ glycogen synthesis Adipose tissue : ↓ lipolysis and release of FFA Beta cells of pancreas, endothelial cells, …

  21. Physiological insulin production 20 - 40 units per day Basal secretion Suppresses glucose production between meals and overnight Nearly constant levels, pulsatile production (5 – 15 min interval) 50% of daily needs Bolus secretion (Mealtime or Prandial) Limits hyperglycemia after meals Immediate rise and sharp peak at 1 hour 10% to 20% of total daily insulin requirement at each meal 6-20

  22. Endogenous – physiological insulin secretion Endogenous secretion Prandial secetion Baal secretion Insulinemia B L D Time B, breakfast; L, lunch; D, dinner; HS, bedtime. Adapted from: 1. Leahy JL. In: Leahy JL, Cefalu WT, eds. Insulin Therapy. New York, NY: Marcel Dekker, Inc.; 2002. 2. Bolli GB et al. Diabetologia. 1999;42:1151-1167.

  23. Prandial insulin secretion • According to regulatory mechanism Cephalic phase - CNS Gastrointestinal phase – enlargement of gastric wall and proximal parts of intestinum Substrates phase – nutrients (glycaemia!) • According to type of secretion in time • Early phase: 30 minutes - stored insulin in granules • Late phase: newly produced insulin, last as hyperglycaemia occurs • In 120 min. period after meal, hyperglycaemia should be normalized.

  24. glucose IGT/diabetes Healthy indiv. Early phase late phase of insulin secretion Insulin response

  25. Classification of DMADA 1997, IDF 1999

  26. Symptoms • polyuria • polydipsia • weight lost • dehydratation • acidosis • infections

  27. Diagnosis A: DM 1. Symptoms + random glycaemia ≥ 11,1mmol/l 2. Fasting plasma glucose ≥ 7,0 mmol/l 3. Glycaemia in 120. min of OGTT ≥ 11,1mmol/l B: Borderline disorder of glucose homeostasis IFG – fasting plasma glucose 5,6 – 6,9 mmol/l IGT - glycaemia in 120. min of OGTT 7,8 -11,01mmol/l

  28. Autoimmune type 1 DM -autoimmune B-cell loss in genetic predisposition - circulating antibodies: - islet-cell autoantibodies (ICA) - insulin autoantibodies (IAA) - glutamic acid decarboxylase antibodies (GAD) = insulitis, main mediators – T-lymfocytes - LADA - latent autoimmune diabetes of adults

  29. Type 1 DM - phases • Genetic predisposition • Trigger mechanism • Autoimmune process • Decrease of insulin secretion • Hyperglycaemia, residual insulin secretion = diagnosed DM • Complete lost of insulin secretion

  30. Development of B-cells failure Genetic predisposition Immune disorder Normal insulin release Progressive impairment of insulin release 100 50 Total amount of b-cells (%) diabetes „Honeymoon“ phase  birth Time (years)

  31. Treatment of DM type 1 : Absolute insulin replacement therapy!!

  32. Diabetes mellitus type 2 • Imbalance between insulin secretion and its function at periphery 2 major disorders: • Insulin resistance • Insulin deficiency (relative)

  33. Prevalence of abnormal glucose tolerance

  34. Worldwide prevalence of DM (according to WHO)

  35. Manifestation of DM Postprandial glycaemia glycemia Fasting glycaemia 7mmol/l Insulin resistance β-cells function Insulin secretion - 20 -10 0 10 20 30 years Nature development of DM

  36. Patophysiology of type 2 DM • Insulin resistance • Insufficient suppression of liver production of glucose • quantitative and qualitative disorder in insulin production

  37. Insulin resistance • Decrease of insulin response at periphery • ½ genetics (mutation of gene for insulin receptors, for glucose transporters, cells enzymes, IRS-1 etc.) • ½ others (metabolic, hormonal and nervous infl., stress, …) • Disorder in efficacy of insulin • Normal plasmatic insulin level causes decreased biological response in organism

  38. Disorder in balance: IR/IS Insulin („transfer capacity“) Glucose („size of baggage“)

  39. IR → compensatory hyperinsulinemia

  40. IR → decrease of insulin secretion

  41. Function of insulin Liver : ↓ gluconeogenesis ↑ protein synthesis ↓ glycogenolysis ↓ FFA oxidation Muscle: ↑absorption and glucose oxidation ↑ glycogen synthesis Adipose tissue : ↓ lipolysis and release of FFA Beta cells of pancreas, endothelial cells, …

  42. Insulin resistance Liver: ↑ glucose production in liver (glycogenolysis and gluconeogenesis) ++ Muscle: ↓ glucose utilization +++ Adipose tissue: ↑lipolysis, ↑ FFA +

  43. Insufficient activity of insulin leads to disorder in metabolism of : • carbohydrates – hyperglycaemia • lipids – lipolysis, ↑ TG, ↑ FFA, ↓ HDL • proteins – proteolysis, protein degradation • minerals – resorption of Na in kidneys, metabolism of Ca

  44. Insulin resistance FFA TG VLDL Insulin Insulin inhibits hormon-senzitive lipase physiology FFA TG Insulin

  45. Who has a high risk of DM type 2? • Genetically risky individuals • Obese – BMI > 25 • Abdominal obesity: waist circumference > 88cm in women > 102cm in men • Positive FH – relatives with DM2 • IGT, GDM in anamnesis • Hypertension, dyslipidemia, CVD • taking diabetogennous drugs • Ethnics groups

More Related